The new design tool lets anyone use text prompts to create prototypes, slides, and one-pagers. The jury's still out if it does a good job. Reading time 2 minutes Wall Street seems to think Anthropic’s ...

As a staff writer for Forbes Advisor, SMB, Kristy helps small business owners find the tools they need to keep their businesses running. She uses the experience of managing her own writing and editing ...

Figma, Inc. is an AI-powered design platform that enables seamless collaboration across the entire product development lifecycle. Its products include FigJam, Figma Slides, Figma Design, Figma Draw, ...

New York Post may receive revenue from affiliate and advertising partnerships for sharing this content and/or when you make a purchase. Create just keeps creating, but it’s not just creatine this time ...

Mike Krieger, Anthropic’s chief product officer, resigned from the board of interface design company Figma on April 14. His departure was disclosed to the U.S. Securities and Exchange Commission by ...

The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or cryptocurrencies for sale or facilitate trading. Coinbase pays us for ...

Anthropic today launched Claude Design, a new product from its Anthropic Labs division that allows users to create polished visual work — designs, interactive prototypes, slide decks, one-pagers, and ...

A new product from Anthropic’s Claude allows users to create designs, prototypes, and slides with the use of artificial intelligence. And some of its rivals are already reeling. Titled Claude Design, ...

Everything you need to know about making your own cryptocurrency Allie is a financial writer and editor with over five years of experience. An investment banker turned journalist, she has previously ...

Canva Create 2026 will take place on April 16 at Hollywood Park in Los Angeles. There is a paid in-person option as well as an online option that will be free, continuing the hybrid model used in ...

Scientists have identified a set of genetic variants that could help to explain why responses to obesity drugs vary markedly from person to person 1. The large sample size makes the findings ...